Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2007

Jun 4, 2007

34807_dirs_2007-06-04_8cd59637-59c2-4977-9b52-e1a314699ddd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2007-06-01

Reporting Person: Schneider Debra A (Vice President and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-06-01 Purchase Option $.71 A 33334 Acquired 2017-05-31 Common Stock (33334) Direct
2007-06-01 Purchase Option $.71 A 33333 Acquired 2017-05-31 Common Stock (33333) Direct
2007-06-01 Purchase Option $.71 A 33333 Acquired 2017-05-31 Common Stock (33333) Direct

Holdings (Non-Derivative)

Security Shares Ownership
No Securities Owned 0 Direct

Footnotes

F1: Common Stock, par value $.01 per share of Transgenomic, Inc.